Guatemala vs Iraq: Cause of death, by non-communicable diseases, ages 5-14
Guatemala
32.2%
in 2021
Iraq
31.4%
in 2021
Guatemala rank
108th
Iraq rank
111th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Guatemala
- Iraq
How they compare
Guatemala currently reports 32.2% against 31.4% in Iraq, a difference of 0.8%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Iraq ahead.
Guatemala ranks 108th and Iraq ranks 111th of 185 countries.
Across the 3 decades both report, Guatemala averaged higher in 2 and Iraq in 1.
Head to head by decade
| Decade | Guatemala | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.3% | 30.3% | 6.0% | Iraq |
| 2010s | 32.8% | 24.8% | 8.0% | Guatemala |
| 2020s | 32.9% | 31.8% | 1.0% | Guatemala |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Guatemala or Iraq?
- Guatemala, at 32.2% against 31.4% in Iraq as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Guatemala and Iraq?
- 0.8%, with Guatemala ahead.
- How many years of comparable data are there for Guatemala and Iraq?
- 6 years are reported by both, from 2000 to 2021.
- How do Guatemala and Iraq rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Guatemala ranks 108th and Iraq ranks 111th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.